Deep Dive: Market Access
pharmaphorum
APRIL 30, 2021
It’s fair to say this is the most interesting time ever for market access. A recent analysis delves into the challenges companies face in getting digital health technologies reimbursed and presents recommendations for how they can find a smoother path to market. Time for a NICE change. How will NICE fare in a post-Brexit world?
Let's personalize your content